http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1253339-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_207a93bf1d29029ffcc1a30a439819b8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-831
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6429
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21005
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-74
filingDate 1970-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1971-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1253339-A
titleOfInvention Preparation of a prothrombin complex
abstract 1,253,339. Prothrombin complex. BAXTER LABORATORIES Inc. 28 May, 1970 [19 June, 1969], No. 25674/70. Heading A5B. A prothrombin complex useful in the treatment of haemorrhagic diseases is prepared by suspending a Cohn Plasma Fraction II+III, III, III-O, IV-1 or IV-1+IV-4 in physiological saline, adjusting the pH to 6.8-7.2, adding to the supernatant tribasic calcium phosphate, collecting the precipitate (containing adsorbed protein) and mixing it with 0.05M to 0.2M trisodium citrate solution, collecting the supernatant and subjecting it to two successive precipitations with polyethylene glycol of M.W. from 200 to 20,000, first at pH 6.8-8.0 and a final concentration of 5-10% PEG (precipitate rejected) and then at pH 5.0-5.4 and a final PEG concentration of at least 20%, the second precipitate, which is the complex, containing the prothrombin being collected. The final complex may be suspended in citrated saline for direct use by injection or, lyophilized to give a storable product.
priorityDate 1969-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8458
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19221
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID325881
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00734
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29251
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID27367
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280685
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43736
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409206349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6224
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5R537
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452135712
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395306
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14061
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP18292
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24456
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID451158
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID250453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ19AZ8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCAAC63054

Total number of triples: 37.